Blueprint Medicines Corporation announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT® (avapritinib) for the treatment of adults with indolent systemic mastocytosis (ISM). All U.S. patients with ISM now have access to the first and only approved medicine designed to treat ...

Abbott announced its Assert-IQ™ insertable cardiac monitor (ICM) has received U.S. Food and Drug Administration (FDA) clearance, giving physicians a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats.

This clearance builds on Abbott's ...

Sintetica S.A., an international pharmaceutical company with manufacturing facilities in Switzerland, announces the launch of Lidocaine Hydrochloride Injection, USP 1%, 2% and 4% through its subsidiary Sintetica US.

Sintetica's unique ability to produce sterile injectable drugs has enabled it ...

Anton Jorgensen, MD and Ortho San Antonio has announced the first cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, as an alternative to lumbar spinal fusion surgery. Dr. Jorgensen completed the surgeries at the Foundation Surgical ...

Nexus Pharmaceuticals, Inc. has announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED® (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL ...

Microba Life Sciences Limited, a precision microbiome company, is pleased to announce that it’s next generation testing product range, MetaXplore™ has been launched to healthcare professionals in Australia under a new brand, Co-Biome™.

This delivers on the new healthcare product launch ...